Abstract:Objective Hepatocellular carcinoma, characterized by high mortality rates, often exhibits limited responsiveness to conventional treatments such as surgery, radiotherapy, and chemotherapy. Therefore, identifying a sensitizer for cisplatin has become crucial. Dihydroartemisinin, known for its potent role of tumor treatment, arises as a prospective candidate for cisplatin sensitization in clinical settings. Methods A mouse model of liver tumor was established through chemical induction of DEN/TCPOBOP. Upon successful model establishment, ultrasound was employed to detect tumors, Hematoxylin and eosin staining was conducted for observation of liver tissue pathology, and ELISA was utilized to assess cytokine changes (IFN-γ, IL-2, IL-4, IL-10, TGF-β, IL-1β, CCL2, and CCL21) in peripheral blood, para-tumor tissues, and tumor tissues. The infiltration of CD8 + T cells and macrophages in tumor tissue sections was detected by immunofluorescence. Results Dihydroartemisinin combined with cisplatin obviously restrained the growth of liver tumors in mice and improved the weight and spleen loss caused by cisplatin. Cisplatin treatment of liver tumor mice increased the content of CCL2 and the number of macrophages in tumor tissues and promoted the formation of an immunosuppressive microenvironment. The combination therapy decreased the content of TGF-β in tumor tissues while increasing CCL2 levels in para-tumor tissues. Both combination therapy and cisplatin alone increased the number of CD8 + T cells in tumor tissue, but there was no difference between them. Conclusion Dihydroartemisinin combined with cisplatin obviously prevented the deterioration of liver tumor in hepatocellular carcinoma mice and improve the therapeutic effect of cisplatin by improving the immunosuppressive microenvironment induced by cisplatin. Our findings provide a theoretical basis for considering dihydroartemisinin as an adjuvant drug for cisplatin in the treatment of hepatocellular carcinoma in the future.

Study of apoptotic thershold of cis-diamminedichloroplatinum and adriamycin on hepatocellular carcinoma

Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy.

[Effects of Cisplatin on Telomerase Activity of Human Choroidal Melanoma Cells].

Cisplatin Induces Apoptosis of Hepatocellular Carcinoma LM3 Cells Via Down-Regulation of XIAP.

CDDP Inhibition of Telomerase Activity in Uveal Melanoma Cells

A Study on the Mechanism of Adriamycin-Induced Apoptosis of Human Hepatic Carcinoma Cells

[Inhibitory and Apoptosis Regulating Effects of Adriamycin on Different Human Breast Cancer Cell Lines].

A dynamic study of the cytotoxic effects of hyperthermia combined with cis-diamine dichlorolplatinum (DDP) on human gastric cancer cell lines MKN28 and MKN45 in vitro

[Experimental study of sensitivity to chemotherapeutic agents for human endometrial carcinoma cell line]

Effects Of Okadaic Acid Combined With Cisplatin On The Proliferation And Apoptosis Of Human Lung Adenocarcinoma A549 Cells

Experimental study of the effects of rAd-p53 on the radiosensitivity of human hepatocellular carcionoma

Experimental Study on Antitumor Effect and Renal Toxicity of Arsenic Trioxide During Treatment of Hepatocellular Carcinoma

[Inhibition Effect on Tca8113/CDDP by Antisense Oligonucleotides of Cyclin D1 Combined with Cis Diamminedichloroplatinum].

Dichloroacetate enhances adriamycin-induced hepatoma cell toxicity in vitro and in vivo by increasing reactive oxygen species levels

Enhanced Chemodynamic Therapy and Chemotherapy via Delivery of a Dual Threat ArtePt and Iodo‐Click Reaction Mediated Glutathione Consumption

Dihydroartemisinin breaks the immunosuppressive tumor niche during cisplatin treatment in Hepatocellular carcinoma

Enhancing Cisplatin Efficacy in Hepatocellular Carcinoma with Selenocystine: The Suppression of DNA Repair and Inhibition of Proliferation in Hepatoma Cells

[Basic Research of the Adenovirus-mediated hCTR1 Transfection on the Treatment of Cisplatin Resistant Cervical Cancer]

In Vitro Interactions Between Hydroxycamptothecine and Oxaliplatin on Human Lung Carcinoma Cell Line

COMPARISON OF MORPHOLOGICAL FEATURE AND ULTRASTRUCTURE CHANGES OF APOPTOSIS OF SGC 7901 AND HEPG 2 CELL LINES INDUCED BY CISPLATIN

Diethyldithiocarbamate May Enhance the Antitumor Effect of Adriamycin Nanoparticle-Lipiodol Emulsion